glioblastoma cure

Australian of the Year Professor Richard Scolyer continues to defy the odds, marking 18 months with no recurrence of glioblastoma brain cancer, after his initial diagnosis predicted less than 2 years to live.

After 14 doses of immunotherapy prior to surgery he was amazed there were still no signs of recurrence of his glioblastoma.

Professor Scolyer was the first in the world to receive immunotherapy before removing a brain tumour — the very treatment he had developed with colleagues to treat melanomas.